A TAAR1 partial agonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RO5203648

Item No. 45362

Technical Information
Formal Name
4-(3,4-dichlorophenyl)-4,5-dihydro-2-oxazolamine
CAS Number
1043491-54-8
Molecular Formula
C9H8Cl2N2O
Formula Weight
Purity
≥95%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
NC1=N[C@@H](C2=CC(Cl)=C(C=C2)Cl)CO1
InChi Code
InChI=1S/C9H8Cl2N2O/c10-6-2-1-5(3-7(6)11)8-4-14-9(12)13-8/h1-3,8H,4H2,(H2,12,13)/t8-/m1/s1
InChi Key
HGGPGNSCBBAGJN-MRVPVSSYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    RO5203648 is a partial agonist of trace amine-associated receptor 1 (TAAR1).1 It increases cAMP production in HEK293 cells expressing TAAR1 (EC50s = 4, 6.8, 30, and 31 nM for the mouse, rat, human, and monkey receptors, respectively). RO5203648 (500 nM) increases the firing frequency of dopaminergic and serotonergic neurons in the ventral tegmental area (VTA) and dorsal raphe nucleus (DRN) in brain slices from wild-type but not Taar1-/- mice. It reduces cocaine-induced hyperlocomotion in mice when administered at doses of 1 and 3, but not 10, mg/kg. It also reduces catalepsy induced by haloperidol (Item No. 12014) and reduces immobility time in the forced swim test in rats. RO5203648 (10 mg/kg) increases the percentage of correct responses in an object retrieval task in cynomolgus monkeys and reduces cocaine administration in a self-administration paradigm in rats.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Revel, F.G., Moreau, J.L., Gainetdinov, R.R., et al. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol. Psychiatry 72(11), 934-942 (2012).